QOL Efficacy of Adapted Physical Activity for Patients With Fibromyalgia
Primary Purpose
Fibromyalgia
Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
PHYSICAL ACTIVITY
Sponsored by
About this trial
This is an interventional other trial for Fibromyalgia
Eligibility Criteria
Inclusion Criteria:
Female or male subject, 18 years of age or older, not pregnant, not breastfeeding, not deprived of liberty;
- Subject with fibromyalgia meeting the criteria of the American College of Rheumatology (ACR)
- Subject managed by the Center for Assessment and Pain Management of CHU Timone or addressed to it in consultation / day hospital;
- Subject free from any general illness or serious psychiatric disorders, and any infectious, inflammatory, tumoral, vascular, degenerative or traumatic pathology of the central nervous system, determined during the interrogation;
- Subject not having a history of alcoholism or drug addiction,
- Subject with no contraindication to PET scintigraphy (pregnancy and lactation),
- Subject with no indication of physical activity;
- Subject whose general state and comprehension of French makes it possible to complete a questionnaire;
- Topic with average pain> 4/10 at EN
- Subject affiliated with Social Security
- Subject who has read, understood and signed informed consent after informing and accepting protocol rules
Exclusion Criteria:
• Major subject under legal protection or unable to express their consent: L1121-8 of the CSP
- Subject presenting a contraindication to the practice of physical activity, to scintigraphic scanning by PET,
- Subject deprived of liberty following a judicial or administrative decision
- Subject with psychiatric illness or Personality Disorder making group work difficult
- Subject refusing to participate in the study or not signing the consent
Sites / Locations
- Assistance Publique Des Hopitaux de Marseille
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
PHYSICAL ACTIVITY
CONTROL
Arm Description
Standard support for 12 months (HAS 2010, EULAR 2016) 3 fibromyactiv workshops per week during the first 6 months, or 72 sessions. Each workshop lasts 2 hours of physical activity.
Standard care for 12 months (HAS 2010, EULAR 2016) with Pain Consultation every 3 months.
Outcomes
Primary Outcome Measures
The Fibromyalgia Impact Questionnaire
FIQ Questionnaire was developed in 1991 as a specific measuring instrument for assessing the health status of patients with fibromyalgia. The validation of this adaptation and the evaluation of its psychometric properties were carried out by Perrot in 2002.
self-administered, exploring ten dimensions of the impact of pathology on quality of life.
Scale from 0 to 10, a high figure corresponding to a greater disadvantage or handicap. The analysis of the evolution of the FIQ over time, spontaneously or under treatment, is therefore dimension by dimension, in order to maintain a clinical informative value, as well as by an aggregate score ( corresponding to the algebraic sum of the dimensions evaluated, compared to 100 units). A weighting of the aggregate score is expected when the patient can not assess impact on professional activity.
Secondary Outcome Measures
Full Information
NCT ID
NCT03640806
First Posted
August 17, 2018
Last Updated
August 13, 2020
Sponsor
Assistance Publique Hopitaux De Marseille
1. Study Identification
Unique Protocol Identification Number
NCT03640806
Brief Title
QOL Efficacy of Adapted Physical Activity for Patients With Fibromyalgia
Official Title
QOL Efficacy of Adapted Physical Activity for Patients With Fibromyalgia : Single-center, Prospective, Randomized With Biological and Cerebral Evaluation
Study Type
Interventional
2. Study Status
Record Verification Date
August 2020
Overall Recruitment Status
Completed
Study Start Date
November 15, 2018 (Actual)
Primary Completion Date
June 30, 2020 (Actual)
Study Completion Date
August 10, 2020 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Assistance Publique Hopitaux De Marseille
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Fibromyalgia affects at least 4% of the population. This chronic painful pathology is a source of social exclusion with a major impact on professional activity;
To our knowledge, no study has demonstrated with sufficient evidence the effectiveness of the practice of well-defined adapted physical activity (APA) via a reproducible program of physical activity that has been the mechanisms of action that underlie this efficacy by biology and functional brain imaging (PET CT) in this context.
In addition, the publications mention recruitment difficulties, a high drop-out rate and a difficult maintenance of the benefits of physical activity in the long term, or even a return to the initial level after a few months.
The programs evaluated do not seem to take into account the peculiarities of patients, their coping coping strategies, associated with chronic pain and disability . In order to reinforce the durability of the benefits of our intervention, we make modulating factors of "coping" styles of therapeutic targets in their own right, as well as muscular strength, aerobic capacity or flexibility. Thus, cognitive-behavioral therapy (CBT) procedures validated in the treatment of chronic pain are adapted and transposed to our APA program in order to propose specific strategies.
"Fibromy'activ" aims to act upstream and downstream of the formation of health inequalities found in the population suffering from fibromyalgia and favored by the natural evolution of the disease: These workshops tend to favorably influence the course of life and to define a reproducible interdisciplinary protocol.
It is a question of making accessible and reproducible the practice of adapted physical activity (APA), non-medicinal therapeutic recommended by the HAS since 2010 , by the EULAR in 2016, but not refunded, poorly protocolized therefore not reproducible and little implementation. It is part of the spirit of the amended Health Act with the coming into force of the application decree since March 2017 "Physical Prescription".
Detailed Description
Fibromy'activ, an adapted physical activity program (APA) for patients with fibromyalgia, aims to provide lasting symptomatic relief, to favorably influence the life course, to identify mechanisms of action and to define a reproducible interdisciplinary protocol.
Fibromyalgia affects at least 4% of the population. This chronic painful pathology is a source of social exclusion with a major impact on professional activity . In France, the prevalence of co-morbidities is increased in pain patients . There is a significant impact on health care systems. It is very expensive for the society of about € 7,900 / patient / year.
The fibromyalgia population managed at the Center for Assessment and Treatment of Pain CHU Timone (CETD), is characterized as follows: 50 years of average age, 85% of women with children in 80% of cases. 60% have a level of education lower than the baccalaureate, less than 30% have a professional activity. The duration of the pain before the first consultation is on average 8.1 years. The SPICE score is above average which indicates a higher level of precariousness. It is associated with dysfunctional pain adjustment strategies, psychological distress, low acceptance and poor quality of life. The characteristics are close to European studies
Natural evolution can lead to a total physical, psychological, social deconditioning. A link has been established between the severity of this pathology, a provider of precariousness and the poor physical condition, related to physical inactivity. The reverse has been described , so the practice of APA brings a significant reduction in symptoms .
To our knowledge, no study has demonstrated with sufficient evidence the effectiveness of the practice of well-defined adapted physical activity (APA) via a reproducible program of physical activity that has been the mechanisms of action that underlie this efficacy by biology and functional brain imaging (PET CT) in this context.
In addition, the publications mention recruitment difficulties, a high drop-out rate and a difficult maintenance of the benefits of physical activity in the long term, or even a return to the initial level after a few months.
The programs evaluated do not seem to take into account the peculiarities of patients, their coping coping strategies, associated with chronic pain and disability . In order to reinforce the durability of the benefits of our intervention, we make modulating factors of "coping" styles of therapeutic targets in their own right, as well as muscular strength, aerobic capacity or flexibility. Thus, cognitive-behavioral therapy (CBT) procedures validated in the treatment of chronic pain are adapted and transposed to our APA program in order to propose specific strategies.
"Fibromy'activ" aims to act upstream and downstream of the formation of health inequalities found in the population suffering from fibromyalgia and favored by the natural evolution of the disease: These workshops tend to favorably influence the course of life and to define a reproducible interdisciplinary protocol.
It is a question of making accessible and reproducible the practice of adapted physical activity (APA), non-medicinal therapeutic recommended by the HAS since 2010 (level of proof A), by the EULAR in 2016, but not refunded, poorly protocolized therefore not reproducible and little implementation. It is part of the spirit of the amended Health Act with the coming into force of the application decree since March 2017 "Physical Prescription".
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Fibromyalgia
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
80 (Actual)
8. Arms, Groups, and Interventions
Arm Title
PHYSICAL ACTIVITY
Arm Type
Experimental
Arm Description
Standard support for 12 months (HAS 2010, EULAR 2016) 3 fibromyactiv workshops per week during the first 6 months, or 72 sessions. Each workshop lasts 2 hours of physical activity.
Arm Title
CONTROL
Arm Type
No Intervention
Arm Description
Standard care for 12 months (HAS 2010, EULAR 2016) with Pain Consultation every 3 months.
Intervention Type
Other
Intervention Name(s)
PHYSICAL ACTIVITY
Intervention Description
3 fibromyactiv workshops per week during the first 6 months, or 72 sessions. Each workshop lasts 2 hours of physical activity.
Primary Outcome Measure Information:
Title
The Fibromyalgia Impact Questionnaire
Description
FIQ Questionnaire was developed in 1991 as a specific measuring instrument for assessing the health status of patients with fibromyalgia. The validation of this adaptation and the evaluation of its psychometric properties were carried out by Perrot in 2002.
self-administered, exploring ten dimensions of the impact of pathology on quality of life.
Scale from 0 to 10, a high figure corresponding to a greater disadvantage or handicap. The analysis of the evolution of the FIQ over time, spontaneously or under treatment, is therefore dimension by dimension, in order to maintain a clinical informative value, as well as by an aggregate score ( corresponding to the algebraic sum of the dimensions evaluated, compared to 100 units). A weighting of the aggregate score is expected when the patient can not assess impact on professional activity.
Time Frame
1 hour
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Female or male subject, 18 years of age or older, not pregnant, not breastfeeding, not deprived of liberty;
Subject with fibromyalgia meeting the criteria of the American College of Rheumatology (ACR)
Subject managed by the Center for Assessment and Pain Management of CHU Timone or addressed to it in consultation / day hospital;
Subject free from any general illness or serious psychiatric disorders, and any infectious, inflammatory, tumoral, vascular, degenerative or traumatic pathology of the central nervous system, determined during the interrogation;
Subject not having a history of alcoholism or drug addiction,
Subject with no contraindication to PET scintigraphy (pregnancy and lactation),
Subject with no indication of physical activity;
Subject whose general state and comprehension of French makes it possible to complete a questionnaire;
Topic with average pain> 4/10 at EN
Subject affiliated with Social Security
Subject who has read, understood and signed informed consent after informing and accepting protocol rules
Exclusion Criteria:
• Major subject under legal protection or unable to express their consent: L1121-8 of the CSP
Subject presenting a contraindication to the practice of physical activity, to scintigraphic scanning by PET,
Subject deprived of liberty following a judicial or administrative decision
Subject with psychiatric illness or Personality Disorder making group work difficult
Subject refusing to participate in the study or not signing the consent
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
EMILIE GARRIDO PRADALIE
Organizational Affiliation
APHM
Official's Role
Study Director
Facility Information:
Facility Name
Assistance Publique Des Hopitaux de Marseille
City
Marseille
State/Province
Paca
ZIP/Postal Code
13354
Country
France
12. IPD Sharing Statement
Learn more about this trial
QOL Efficacy of Adapted Physical Activity for Patients With Fibromyalgia
We'll reach out to this number within 24 hrs